Article Text

Download PDFPDF

A randomised controlled trial of aerobic exercise after transient ischaemic attack or minor stroke to prevent cognitive decline: the MoveIT study protocol
  1. H M Boss1,
  2. S M Van Schaik1,
  3. I A Deijle2,
  4. E C de Melker3,
  5. B T J van den Berg4,
  6. E J A Scherder5,
  7. W M J Bosboom1,
  8. H C Weinstein1,
  9. R M Van den Berg-Vos1
  1. 1Department of Neurology, Sint Lucas Andreas Hospital, Amsterdam, The Netherlands
  2. 2Department of Physical Therapy, Sint Lucas Andreas Hospital, Amsterdam, The Netherlands
  3. 3Department of Cardiology, Sint Lucas Andreas Hospital, Amsterdam, The Netherlands
  4. 4Department of Respiratory Medicine, Sint Lucas Andreas Hospital, Amsterdam, The Netherlands
  5. 5Department of Clinical Neuropsychology, VU University, Amsterdam, The Netherlands
  1. Correspondence to RM Van den Berg-Vos; r.vandenberg-vos{at}


Introduction Patients with transient ischaemic attack (TIA) or stroke are at risk for cognitive impairment and dementia. Currently, there is no known effective strategy to prevent this cognitive decline. Increasing evidence exists that physical exercise is beneficial for cognitive function. However, in patients with TIA or stroke who are at risk of cognitive impairment and dementia, only a few trials have been conducted. In this study, we aim to investigate whether a physical exercise programme (MoveIT) can prevent cognitive decline in patients in the acute phase after a TIA or minor ischaemic stroke.

Methods and analysis A single-blinded randomised controlled trial will be conducted to investigate the effect of an aerobic exercise programme on cognition compared with usual care. 120 adult patients with a TIA or minor ischaemic stroke less than 1 month ago will be randomly allocated to an exercise programme consisting of a 12-week aerobic exercise programme and regular follow-up visits to a specialised physiotherapist during the period of 1 year or to usual care. Outcome measures will be assessed at the baseline, and at the 1-year and 2-year follow-up. The primary outcome is cognitive functioning measured with the Montreal Cognitive Assessment (MoCA) test and with additional neuropsychological tests. Secondary outcomes include maximal exercise capacity, self-reported physical activity and measures of secondary prevention.

Ethics and dissemination The study received ethical approval from the VU University Amsterdam Ethics committee (2011/383). The results of this study will be published in peer-reviewed journals and presented at international conferences. We will also disseminate the main results to our participants in a letter.

Trial registration number The Nederlands Trial Register NTR3884.


This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:

View Full Text

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.